References
1a
Ivanov IC.
Raev LD.
Synth. Commun.
1986,
16:
1679
1b
Ivanov IC.
Raev LD.
Liebigs Ann. Chem.
1987,
1107
1c
Ivanov IC.
Raev LD.
Arch. Pharm.
1995,
328:
53
1d
Raev LD.
Voinova E.
Ivanov IC.
Popov D.
Pharmazie
1990,
45(9):
696
2
Kantlehner W. In Houben-Weyl
4th ed., Part 2, Vol. E 15:
Kropf H.
Schaumann E.
Thieme;
Stuttgart:
1993.
p.2197
3
X-ray Crystal Structure Analyses: atomic coordinates, bond lengths [Å] and angles [deg], anisotropic displacement parameters, hydrogen coordinates, torsion angles [deg] have been deposited at Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK, under deposition numbers CCDC 177460 for 6a, CCDC 177461 for 8a, CCDC 177459 for 10e, CCDC 181931 for 11a, CCDC 233450 for 13c, CCDC 177462 for 13h, CCDC 177463 for 15a, CCDC 177464 for 16a, CCDC 177464 for 17a [fax: +44 (1223)336033; homepage: http://www.ccdc.cam.ac.uk].
4 (a) Typical Procedure for the Preparation of Coumarin-enaminoester Adducts (6a,c,e,f,h,i; 8a; 10c-f,h,i; 11a,c,i):
A mixture of 15 mmol of the corresponding coumarin 1a-i and 15 mmol of an enaminoester 2a-c in 40 mL anhyd EtOH was stirred (temperature and period of time are given in Table
[1]
). After cooling, the separated crystals of the corresponding adduct were filtered, washed with cold EtOH and recrystallized, usually from EtOH. If a mixture of products was obtained (TLC monitoring), the solvent was removed in vacuo and the residue was separated by column chromatography on siliga gel.
(b) Systematic names: Ethyl 12-benzoyl-9-ethoxy-11-oxo-8-oxa-10-azatricyclo[7.3.1.0
[2]
[7]
]trideca-2 (7),3,5-triene-13-carboxylate (10e); Ethyl {11-oxo-8-oxa-10-azatricyclo[7.3.1.0
[2]
[7]
]trideca-2,4,6-trien-9-yl}acetate (11a).
5
Claremon DA.
Hirshfield J.
Lumma PK.
McClure DE.
Springer JP.
Synthesis
1986,
144
6
Ethyl 2-Amino-4-(2-hydroxyphenyl)-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxylate (6a) (unpublished data): 1H NMR (400 MHz, DMSO-d
6): δ = 1.02 (t, J = 7.0 Hz, 3 H, CH3), 2.51 (d, 2
J = 16.0 Hz, 1 H, 5-HA), 2.80 (dd, 2
J = 16.0 Hz, 3
J = 7.3 Hz, 1 H, 5-HB), 3.99 (m, 2 H, OCH2), 4.35 (d, 3
J = 7.3 Hz, 1 H, 4-H), 6.67 (m, 1 H, 6′-H), 6.80 (m, 2 H, 3′-H, 5′-H), 6.99 (m, 1 H, 4′-H.), 6.00-8.00 (br, 2 H, NH2), 9.45 (s, 1 H, NH or OH), 9.59 (s, 1 H, OH or NH). 13C NMR (100.6 MHz, DMSO-d
6): δ = 13.5 (CH3), 28.7 (C-4), 36.1 (C-5), 57.4 (O-CH2), 74.9 (C-3), 114.0 (Carom.), 117.9 (Carom.), 125.5 (Carom.), 126.5 (Carom.), 128.4 (Carom.), 152.4 (C-2′), 153.4 (C-2.), 167.4 (C=O, ester), 170.0 (C=O, lactam).
Salient NMR signals: O-Acetyl derivative (15a): mp 170-172 °C (toluene). 1H NMR (300 MHz, DMSO-d
6): δ = 2.32 (s, 3 H, OCOCH3), 7.03-7.25 (m, 6 H, 4Harom and NH2), 9.73 (s, 1 H, lactam-NH). N-Acetyl derivative (16a): mp 184-186 °C (EtOH). 1H NMR (300 MHz, DMSO-d
6): δ = 2.21 (s, 3 H, NCOCH3), 9.61 (br s, 1 H, OH), 10.68 (s, 1 H, amide-NH), 11.49 (s, 1 H, lactam-NH). O,N-Diacetyl derivative (17a): mp 180-181 °C (EtOH). 1H NMR (300 MHz, CDCl3): δ = 2.23 (s, 3 H, NCOCH3), 2.34 (s, 3 H, OCOCH3), 10.96 (s, 1 H, amide-NH), 11.98 (s, 1 H, lactam-NH). 13C NMR (75 MHz, CDCl3): δ = 21.0 (OCOCH3), 25.3 (NCOCH3).
7
Ethyl 2-Amino-4-(2-hydroxy-5-nitrophenyl)-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxylate (6f) (unpublished data): 1H NMR (400 MHz, DMSO-d
6): δ = 1.04 (m, 3 H, CH3), 2.50 (d, 2
J = 16.2 Hz, 1 H, 5-HA), 2.80 (dd, 3
J = 7.3 Hz, 2
J = 16.2 Hz, 1 H, 5-HB), 3.95 (m, 2 H, OCH2), 4.40 (d, 3
J = 7.3 Hz, 1 H, 4-H), 7.01 (d, 1 H, 3′-H), 7.75 (s, 1 H, 6′-H), 8.03 (d, 1 H, 4′-H.), 6.20-7.80 (br, 2 H, NH2), 9.80 (s, 1 H, NH or OH), 11.35 (br s, 1 H, OH or NH). 13C NMR (100.6 MHz, DMSO-d
6): δ = 14.8 (CH3), 30.5 (C-4), 36.9 (C-5), 58.6 (O-CH2), 75.0 (C-3), 115.9
(Carom.-3′), 123.1 (Carom.-6′), 124.7 (Carom.-4′), 131.7
(Carom.-1′), 139.8 (Carom.-5′), 154.6 (C-2), 162.0 (Carom.-2′), 168.2 (C=O, ester), 170.3 (C=O, lactam).
Salient 1H NMR signals: N-Acetyl derivative (16b): mp 218-220 °C (2-PrOH). 1H NMR (250 MHz, DMSO-d
6): δ = 2.23 (s, 3 H, NCOCH3), 10.72 (s, 1 H, amide-NH), 11.40 (s, 1 H, lactam-NH), 11.5 (br s, 1 H, OH). O,N-Diacetyl derivative (17b): mp 165-166.5 °C (2-PrOH). 1H NMR (250 MHz, CDCl3): δ = 2.29 (s, 3 H, NCOCH3), 2.40 (s, 3 H, OCOCH3), 11.12 (s, 1 H, amide-NH), 12.01 (s, 1 H, lactam-NH).
8 Raev, L. D.; Ivanov, I. C. Third National Congress of Pharmacy (Abstracts), 17-19 October 1996, Sofia - Panichishte (Bulgaria); poster 11.P5.